|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||
| Cash | ||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||
| Trust account receivable | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Cash held in Trust Account | ||||||||||||||||||
| Total Assets | ||||||||||||||||||
| Current liabilities: | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Due to Continental | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total due to Continental | ||||||||||||||||||
| Accrued expenses | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Promissory Notes—related party | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total promissory Notes—related party | ||||||||||||||||||
| Working capital loan—related party | ||||||||||||||||||
| Working Capital Loans—related party | ||||||||||||||||||
| Promissory Notes—related party | ||||||||||||||||||
| Backstop agreement liability | ||||||||||||||||||
| Advances from related party | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total advances from related party | ||||||||||||||||||
| Advances from Sponsor | ||||||||||||||||||
| Working Capital Loans—related party | ||||||||||||||||||
| Due to redeeming shareholders | ||||||||||||||||||
| Derivative warrant liabilities | ||||||||||||||||||
| Deferred underwriting commissions | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 114,053 and 2,000,000 shares at redemption value of approximately $11.42 and $11.29 per share as of June 30, 2025 and December 31, 2024, respectively | ||||||||||||||||||
| Class A Ordinary Shares | ||||||||||||||||||
| Total class A ordinary shares subject to possible redemption, $0.0001 par value; 114,053 and 2,000,000 shares at redemption value of approximately $11.42 and $11.29 per share as of June 30, 2025 and December 31, 2024, respectively | ||||||||||||||||||
| Shareholders’ Deficit: | ||||||||||||||||||
| Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding as of June 30, 2025 and December 31, 2024 | ||||||||||||||||||
| Ordinary shares value | ||||||||||||||||||
| Class A Ordinary Shares | ||||||||||||||||||
| Class B Ordinary Shares | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Total shareholders’ deficit | ||||||||||||||||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit | ||||||||||||||||||
Loading...
